ARCHIVES

Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Cancer Control Survey “a Flop,” Advisory committee Members Say

October 11, 1974

Data-Dredging? Don’t Try It, FDA Says.

May 11, 2007

CPRU Program Gets Basic Concept Approval

October 2, 1987

Bach: LCA Center Certification Untrustworthy; CISNET Models Don’t Match

May 9, 2014

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007